Sopharma Trading Ad (0K3C)
LSE
年末 2023年12月31日 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
BGN (BGN) | BGN (BGN) | BGN (BGN) | BGN (BGN) | BGN (BGN) | BGN (BGN) | BGN (BGN) | BGN (BGN) | |
総売上 | 613.13M | 721.39M | 887.79M | 958.58M | 1.17B | 1.34B | 1.49B | 1.68B |
営業利益 | 10.18M | 9.84M | 10.99M | 11.94M | 21.37M | 18.03M | 43.75M | 48.69M |
税引前収入 | 12.42M | 11.35M | 10.19M | 10.18M | 13.92M | 9.44M | 12.39M | 34.21M |
純利益 | 10.87M | 9.34M | 8.72M | 8.92M | 11.48M | 8.05M | 9.08M | 29.21M |
優先配当 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | 0.33 | 0.284 | 0.265 | 0.26 | 0.335 | 0.235 | 0.265 | 0.852 |
EBIT | 10.6M | 10.05M | 11.25M | 11.94M | 21.37M | 18.03M | 43.75M | 48.69M |
EBITDA | 14.19M | 15M | 19.93M | 27.42M | 41.41M | 46.59M | 73.74M | 80.76M |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約